Sections
Title | Starting Page | Number of Pages |
---|
1 Table of Contents | 2 | 7 |
1.1 List of Tables | 5 | 3 |
1.2 List of Figures | 8 | 1 |
2 Introduction | 9 | 1 |
2.1 Laparoscopic Instruments Overview | 9 | 1 |
3 Products under Development | 10 | 5 |
3.1 Laparoscopic Instruments - Pipeline Products by Stage of Development | 10 | 1 |
3.2 Laparoscopic Instruments - Pipeline Products by Territory | 11 | 1 |
3.3 Laparoscopic Instruments - Pipeline Products by Regulatory Path | 12 | 1 |
3.4 Laparoscopic Instruments - Pipeline Products by Estimated Approval Date | 13 | 1 |
3.5 Laparoscopic Instruments - Ongoing Clinical Trials | 14 | 1 |
4 Laparoscopic Instruments - Pipeline Products under Development by Companies | 15 | 4 |
4.1 Laparoscopic Instruments Companies - Pipeline Products by Stage of Development | 15 | 2 |
4.2 Laparoscopic Instruments - Pipeline Products by Stage of Development | 17 | 2 |
5 Laparoscopic Instruments Companies and Product Overview | 19 | 44 |
5.1 Adroit Motion, LLC Company Overview | 19 | 1 |
5.1.1 Adroit Motion, LLC Pipeline Products &Ongoing Clinical Trials Overview | 19 | 1 |
5.2 Agile EndoSurgery, Inc. Company Overview | 20 | 1 |
5.2.1 Agile EndoSurgery, Inc. Pipeline Products &Ongoing Clinical Trials Overview | 20 | 1 |
5.3 Alesi Surgical Ltd. Company Overview | 21 | 1 |
5.3.1 Alesi Surgical Ltd. Pipeline Products &Ongoing Clinical Trials Overview | 21 | 3 |
5.4 De La Salle University Medical Center Company Overview | 24 | 1 |
5.4.1 De La Salle University Medical Center Pipeline Products &Ongoing Clinical Trials Overview | 24 | 1 |
5.5 Delft University of Technology Company Overview | 25 | 1 |
5.5.1 Delft University of Technology Pipeline Products &Ongoing Clinical Trials Overview | 25 | 1 |
5.6 Gordian Surgical, LLC Company Overview | 26 | 1 |
5.6.1 Gordian Surgical, LLC Pipeline Products &Ongoing Clinical Trials Overview | 26 | 4 |
5.7 i360medical Limited Company Overview | 30 | 1 |
5.7.1 i360medical Limited Pipeline Products &Ongoing Clinical Trials Overview | 30 | 1 |
5.8 Indian Institute of Technology Bombay Company Overview | 31 | 1 |
5.8.1 Indian Institute of Technology Bombay Pipeline Products &Ongoing Clinical Trials Overview | 31 | 1 |
5.9 Janus Development Group Inc Company Overview | 32 | 1 |
5.9.1 Janus Development Group Inc Pipeline Products &Ongoing Clinical Trials Overview | 32 | 2 |
5.10 Koc Universitesi Company Overview | 34 | 1 |
5.10.1 Koc Universitesi Pipeline Products &Ongoing Clinical Trials Overview | 34 | 2 |
5.11 Lenvitz Medical Solutions Pvt. Ltd. Company Overview | 36 | 1 |
5.11.1 Lenvitz Medical Solutions Pvt. Ltd. Pipeline Products &Ongoing Clinical Trials Overview | 36 | 1 |
5.12 Lightpoint Medical Ltd Company Overview | 37 | 1 |
5.12.1 Lightpoint Medical Ltd Pipeline Products &Ongoing Clinical Trials Overview | 37 | 1 |
5.13 Medical Sewing Solutions LLC Company Overview | 38 | 1 |
5.13.1 Medical Sewing Solutions LLC Pipeline Products &Ongoing Clinical Trials Overview | 38 | 1 |
5.14 MedInno Company Overview | 39 | 1 |
5.14.1 MedInno Pipeline Products &Ongoing Clinical Trials Overview | 39 | 1 |
5.15 Miret Surgical Company Overview | 40 | 1 |
5.15.1 Miret Surgical Pipeline Products &Ongoing Clinical Trials Overview | 40 | 1 |
5.16 neoSurgical Limited Company Overview | 41 | 1 |
5.16.1 neoSurgical Limited Pipeline Products &Ongoing Clinical Trials Overview | 41 | 1 |
5.17 Onciomed, Inc. Company Overview | 42 | 1 |
5.17.1 Onciomed, Inc. Pipeline Products &Ongoing Clinical Trials Overview | 42 | 1 |
5.18 Resultados y Calidad del Sistema Sanitario Publico de Andalucia Company Overview | 43 | 1 |
5.18.1 Resultados y Calidad del Sistema Sanitario Publico de Andalucia Pipeline Products &Ongoing Clinical Trials Overview | 43 | 1 |
5.19 Saturix Ltd Company Overview | 44 | 1 |
5.19.1 Saturix Ltd Pipeline Products &Ongoing Clinical Trials Overview | 44 | 1 |
5.20 Teijin Pharma Ltd Company Overview | 45 | 1 |
5.20.1 Teijin Pharma Ltd Pipeline Products &Ongoing Clinical Trials Overview | 45 | 1 |
5.21 Teleflex Inc Company Overview | 46 | 1 |
5.21.1 Teleflex Inc Pipeline Products &Ongoing Clinical Trials Overview | 46 | 2 |
5.22 The University of Utah Company Overview | 48 | 1 |
5.22.1 The University of Utah Pipeline Products &Ongoing Clinical Trials Overview | 48 | 2 |
5.23 TrusTECH Company Overview | 50 | 1 |
5.23.1 TrusTECH Pipeline Products &Ongoing Clinical Trials Overview | 50 | 1 |
5.24 University College Cork Company Overview | 51 | 1 |
5.24.1 University College Cork Pipeline Products &Ongoing Clinical Trials Overview | 51 | 1 |
5.25 University of California San Francisco Company Overview | 52 | 1 |
5.25.1 University of California San Francisco Pipeline Products &Ongoing Clinical Trials Overview | 52 | 1 |
5.26 University of Colorado Company Overview | 53 | 1 |
5.26.1 University of Colorado Pipeline Products &Ongoing Clinical Trials Overview | 53 | 1 |
5.27 University of Missouri Company Overview | 54 | 1 |
5.27.1 University of Missouri Pipeline Products &Ongoing Clinical Trials Overview | 54 | 1 |
5.28 University of Nebraska Company Overview | 55 | 1 |
5.28.1 University of Nebraska Pipeline Products &Ongoing Clinical Trials Overview | 55 | 1 |
5.29 University of South Florida Company Overview | 56 | 1 |
5.29.1 University of South Florida Pipeline Products &Ongoing Clinical Trials Overview | 56 | 4 |
5.30 Vanderbilt University Company Overview | 60 | 1 |
5.30.1 Vanderbilt University Pipeline Products &Ongoing Clinical Trials Overview | 60 | 2 |
5.31 ZSX Medical, LLC Company Overview | 62 | 1 |
5.31.1 ZSX Medical, LLC Pipeline Products &Ongoing Clinical Trials Overview | 62 | 1 |
6 Laparoscopic Instruments- Recent Developments | 63 | 39 |
6.1 Nov 16, 2016: Medtronic Releases FY16 Integrated Performance Report | 63 | 1 |
6.2 Nov 09, 2016: TransEnterix Reports Operating Results for the Third Quarter 2016 | 63 | 1 |
6.3 Nov 07, 2016: Surgical Innovations Group Acquires Laparoscopic Instruments Business and Related Assets of Surgical Dynamics | 64 | 1 |
6.4 Nov 02, 2016: Mauna Kea Technologies Reports Third Quarter 2016 Sales | 64 | 1 |
6.5 Oct 27, 2016: Stryker reports third quarter 2016 results | 64 | 1 |
6.6 Oct 27, 2016: Teleflex Reports Third Quarter 2016 Results | 65 | 3 |
6.7 Oct 27, 2016: Integra LifeSciences Reports Third Quarter 2016 Financial Results | 68 | 1 |
6.8 Oct 27, 2016: CONMED Announces Third Quarter 2016 Financial Results | 68 | 1 |
6.9 Oct 26, 2016: Surgical Innovations Group: CE Certification for YelloPort Elite | 69 | 1 |
6.10 Oct 26, 2016: LeMaitre Q3 2016 Record Sales $23.2 mm (+22%), Record Op. Income $5.3 mm (+61%) | 70 | 1 |
6.11 Oct 26, 2016: Merit Medical Reports Sales Up 15.3% for the Quarter Ended September 30, 2016 | 70 | 1 |
6.12 Oct 18, 2016: neoSurgical Announces CE Mark Approval of the neoClose Laparoscopic Port Closure Device | 71 | 1 |
6.13 Sep 21, 2016: Mauna Kea Technologies Reports 1H 2016 Financial Results | 72 | 1 |
6.14 Sep 19, 2016: Medeon Biodesign Receives FDA 510(k) Clearance for Abclose - Laparoscopic Port Site Closure Device | 73 | 1 |
6.15 Sep 15, 2016: Medtronic Names Mark Ploof Senior Vice President of Global Operations and Business Services | 74 | 1 |
6.16 Sep 06, 2016: Gordian Surgical Receives CE Clearance For TroClose1200 | 75 | 1 |
6.17 Sep 05, 2016: Teijin Publishes Integrated Report 2016 | 75 | 1 |
6.18 Aug 31, 2016: Surgical Innovations Group: Interim results for the six months ended 30 June 2016 | 76 | 1 |
6.19 Aug 25, 2016: Medtronic Reports First Quarter Financial Results | 77 | 3 |
6.20 Aug 22, 2016: Peconic Bay Medical Center completes first percutaneous procedure on an umbilical hernia in the United States | 80 | 1 |
6.21 Aug 17, 2016: Magnetic Surgical System by Levita Magnetics Receives FDA Clearance | 80 | 1 |
6.22 Aug 15, 2016: Teleflex Launches New Second-Generation 2.9 mm Percuvance System A Breakthrough Advance that Makes Percutaneous Approach to Laparoscopic Procedures Even Less Invasive | 81 | 1 |
6.23 Aug 05, 2016: TransEnterix Reports Operating Results for the Second Quarter 2016 | 82 | 1 |
6.24 Jul 28, 2016: Teleflex Reports Second Quarter 2016 Results | 83 | 1 |
6.25 Jul 28, 2016: Integra LifeSciences Reports Second Quarter 2016 Financial Results | 84 | 2 |
6.26 Jul 27, 2016: Merit Medical Reports Sales Up 9.4% for the Quarter Ended June 30, 2016 | 86 | 1 |
6.27 Jul 27, 2016: CONMED Announces Second Quarter 2016 Financial Results | 87 | 1 |
6.28 Jul 27, 2016: LeMaitre Q2 2016 Record Sales $22.4mm (+13%), Record Op. Income $3.8mm (+35%) | 88 | 1 |
6.29 Jul 26, 2016: Merit Medical Announces Appointment of New Director | 88 | 1 |
6.30 Jul 21, 2016: Stryker reports second quarter 2016 results | 89 | 1 |
6.31 Jul 12, 2016: Mauna Kea Technologies Reports Second Quarter 2016 Sales | 90 | 1 |
6.32 Jun 30, 2016: NuVasive Agrees to Settle Patent Litigation With Medtronic | 91 | 1 |
6.33 Jun 06, 2016: Medtronic Outlines Future Growth Vision at Investor Day | 91 | 1 |
6.34 May 31, 2016: Medtronic Reports Fourth Quarter and Fiscal Year 2016 Financial Results | 92 | 2 |
6.35 May 25, 2016: TransEnterix Appoints Theodore Pappas, MD Senior Surgical Officer | 94 | 1 |
6.36 May 23, 2016: Gordian Surgical Begins First-in-Human Trials | 95 | 1 |
6.37 May 20, 2016: Narvitas Medical Devices International Announces the first successful Bariatric application of its Proprietary LapDome Device | 95 | 1 |
6.38 May 17, 2016: Mauna Kea Technologies Appoints Pierre Forest As Chief Operating Officer | 96 | 1 |
6.39 May 12, 2016: Solos Endoscopy Sales Increase by 20% for First Quarter 2016 | 96 | 1 |
6.40 May 11, 2016: Teleflex Raises USD400 Million in Public Offering of 4.875% Notes Due 2026 | 97 | 1 |
6.41 May 10, 2016: TransEnterix Reports Operating Results for the First Quarter 2016 | 97 | 1 |
6.42 Apr 11, 2016: neoSurgical Expands Indications for neoClose Device | 98 | 1 |
6.43 Mar 03, 2016: Solos Endoscopy FDA Establishment Registration &Device Listing Renewed for 2016 | 99 | 1 |
6.44 Mar 01, 2016: neoSurgical Reports New Commercial Milestone of 8000 US Procedures Using Its FDA-Cleared neoClose Device for Closing Port Site Incisions after Laparoscopic and Robotic Surgeries | 99 | 1 |
6.45 Feb 26, 2016: Narvitas Medical Devices International Announces Commercialisation of LapDome | 100 | 1 |
6.46 Feb 22, 2016: Narvitas Medical Devices International Announces CE Mark and Commercialisation of its Proprietary LapDome Device | 100 | 1 |
6.47 Jan 19, 2016: neoSurgical Begins Postmarket Surveillance Study of FDA-Cleared neoClose Versus Standard of Care for Closing Port Site Incisions in Lap and Robotic Surgeries | 101 | 1 |
7 Appendix | 102 | 4 |
7.1 Methodology | 102 | 3 |
7.2 About GlobalData | 105 | 1 |
7.3 Contact Us | 105 | 1 |
7.4 Disclaimer | 105 | 1 |